/
Metabolic & Endocrine
Overweight or Obese
3
Pipeline Programs↗
5
Active Trials↗
4
Companies Involved↗
Overweight or Obese is an early-stage landscape with 3 programs across 4 companies. The most active players are Carmot Therapeutics, Inc., Alveus Therapeutics, Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 11
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
8
clinical trials
Completed2 · 25%
Active, not recruiting2 · 25%
Not yet recruiting2 · 25%
Terminated1 · 13%
Recruiting1 · 13%
Clinical Trials
Trial Activity
8 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)